SEC Form 4 · accession 0001209191-15-028041

Adamas Pharmaceuticals Inc · ADMS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Mar 17, 2015

Accepted (ET)

Mar 19, 2015 · 7:53 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001328143

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 17, 2015	M	1,900	$1.875	A	1,908	D
Common Stock^F1	Mar 17, 2015	S	1,900	$18.00	D	8	D
Common Stock	Mar 17, 2015	S	2,700	$18.00	D	417,748	I	Gregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common Stock^F1	Mar 18, 2015	M	4,600	$1.875	A	4,608	D
Common Stock^F2,F1	Mar 18, 2015	S	4,600	$18.0007	D	8	D
Common Stock^F3	Mar 18, 2015	S	9,420	$18.0045	D	408,328	I	Gregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common Stock^F1	Mar 19, 2015	M	12,320	$1.875	A	12,328	D
Common Stock^F1	Mar 19, 2015	S	2,320	$18.00	D	10,008	D
Common Stock	Mar 19, 2015	S	2,148	$18.00	D	406,180	I	Gregory T Went & Marjorie S Went ttees Went Family Living Trust dtd 03/24/11
Common Stock	holding	—	—		—	6,666	I	Gregory T Went Cust - Bridget Went Under CA Uniform Transfers to Minors Act
Common Stock	holding	—	—		—	6,666	I	Gregory T Went Cust - Cora Went Under CA Uniform Transfers to Minors Act
Common Stock	holding	—	—		—	80,000	I	Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Bridget Elise Went
Common Stock	holding	—	—		—	80,000	I	Gregory T Went & Marjorie S Went ttees 2012 Irr Trust FBO Cora Margaret Went

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$1.875	Mar 17, 2015	M	1,900	D	—	Sep 12, 2016	Common Stock	1,900	248,100	D
Stock Option (Right to Buy)^F4	$1.875	Mar 18, 2015	M	4,600	D	—	Sep 12, 2016	Common Stock	4,600	243,500	D
Stock Option (Right to Buy)^F4	$1.875	Mar 19, 2015	M	12,320	D	—	Sep 12, 2016	Common Stock	12,320	231,180	D

F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to 18.02, inclusive.
F3The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to 18.09, inclusive.
F4This option is fully vested and exercisable.